Literature DB >> 17346227

Critical enzymes involved in endocannabinoid metabolism.

Balapal S Basavarajappa1.   

Abstract

Investigations of the pathways involved in the metabolism of endocannabinoids have grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG). The in vivo biosynthesis of AEA has been shown to occur through several pathways mediated by N-acylphosphatidylethanolamide-phospholipase D (NAPE-PLD), a secretory PLA(2) and PLC. 2-AG, a second endocannabinoid is generated through the action of selective enzymes such as phosphatidic acid phsophohydrolase, diacylglycerol lipase (DAGL), phosphoinositide-specific PLC (PI-PLC) and lyso-PLC. A putative membrane transporter or facilitated diffusion is involved in the cellular uptake or release of endocannabinoids. AEA is metabolized by fatty acid amidohydrolase (FAAH) and 2-AG is metabolized by both FAAH and monoacylglycerol lipase (MAGL). The author presents an integrative overview of current research on the enzymes involved in the metabolism of endocannabinoids and discusses possible therapeutic interventions for various diseases, including addiction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346227      PMCID: PMC1939815          DOI: 10.2174/092986607780090829

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  125 in total

Review 1.  Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling.

Authors:  Lucio Cocco; Irene Faenza; Roberta Fiume; Anna Maria Billi; R Stewart Gilmour; Francesco A Manzoli
Journal:  Biochim Biophys Acta       Date:  2006-03-29

2.  Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.

Authors:  Sabatino Maione; Tiziana Bisogno; Vito de Novellis; Enza Palazzo; Luigia Cristino; Marta Valenti; Stefania Petrosino; Vittorio Guglielmotti; Francesco Rossi; Vincenzo Di Marzo
Journal:  J Pharmacol Exp Ther       Date:  2005-11-11       Impact factor: 4.030

3.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

4.  Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-07-03       Impact factor: 5.157

5.  Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.

Authors:  Alex Straiker; Ken Mackie
Journal:  J Physiol       Date:  2005-09-22       Impact factor: 5.182

6.  Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.

Authors:  Donmienne Leung; Alan Saghatelian; Gabriel M Simon; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

7.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

Authors:  Takayuki Yoshida; Masahiro Fukaya; Motokazu Uchigashima; Eriko Miura; Haruyuki Kamiya; Masanobu Kano; Masahiko Watanabe
Journal:  J Neurosci       Date:  2006-05-03       Impact factor: 6.167

8.  Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice.

Authors:  Balapal S Basavarajappa; Ratnakumar Yalamanchili; Benjamin F Cravatt; Thomas B Cooper; Basalingappa L Hungund
Journal:  Neuropharmacology       Date:  2006-01-30       Impact factor: 5.250

9.  Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.

Authors:  Marcello Solinas; Leigh V Panlilio; Gianluigi Tanda; Alexandros Makriyannis; Stephanie A Matthews; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

10.  PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons.

Authors:  Nan Sang; Jian Zhang; Chu Chen
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

View more
  50 in total

Review 1.  Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

Authors:  Pál Gyombolai; Dorottya Pap; Gábor Turu; Kevin J Catt; György Bagdy; László Hunyady
Journal:  Mol Cell Endocrinol       Date:  2011-11-02       Impact factor: 4.102

2.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.

Authors:  Gábor Turu; Péter Várnai; Pál Gyombolai; László Szidonya; László Offertaler; György Bagdy; George Kunos; László Hunyady
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

4.  Metaplasticity of hypothalamic synapses following in vivo challenge.

Authors:  J Brent Kuzmiski; Quentin J Pittman; Jaideep S Bains
Journal:  Neuron       Date:  2009-06-25       Impact factor: 17.173

5.  Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.

Authors:  Balapal S Basavarajappa; Ipe Ninan; Ottavio Arancio
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

Review 6.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

Review 7.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

8.  Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol.

Authors:  Nicola Bernabò; Barbara Barboni; Mauro Maccarrone
Journal:  OMICS       Date:  2013-10-11

9.  Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.

Authors:  Victor M Pulgar; Liliya M Yamaleyeva; Jasmina Varagic; Carolynne M McGee; Michael Bader; Ralf Dechend; Allyn C Howlett; K Bridget Brosnihan
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

Review 10.  Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Authors:  V Kiran Vemuri; David R Janero; Alexandros Makriyannis
Journal:  Physiol Behav       Date:  2007-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.